-
Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-11 Samuel Lawson, Jamie Bryant, Megan Freund, Joshua Dizon, Paul S. Haber, Anthony Shakeshaft, Meryem Jefferies, Michael Farrell
IntroductionThe aim of this paper was to examine the client and psychosocial characteristics associated with polydrug use in patients with alcohol misuse as their primary drug of concern (PDC) seeking treatment from substance use treatment centres.MethodsSelf‐report surveys were undertaken with clients attending 1 of 34 community‐based substance use treatment centres across Australia with alcohol as
-
Young people's alcohol use in and around water: A scoping review of the literature Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-10 Renee N. Carey, Gemma Crawford, Jonine Jancey, Tina Lam, Lauren Nimmo, Gina Trapp, Christina Pollard, Paula Hooper, Justine E. Leavy
IssuesThe surrounding social and commercial context, including alcohol advertising, heavily influences alcohol consumption. Alcohol use is a major risk factor for both fatal and non‐fatal drowning, particularly for young people.ApproachWe conducted a scoping review to explore the peer‐reviewed literature on the use of alcohol by young people (aged 15–34 years) in the context of aquatic environments
-
Smartphone‐delivered approach bias modification for reducing harmful drinking amongst middle–older age adults: Secondary analyses of a single‐arm pilot study Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-06 Georgia L. Bolt, Hugh Piercy, Jennifer Bradshaw, Victoria Manning
IntroductionNovel, scalable, low‐cost interventions are needed to reduce harmful drinking amongst middle–older adults. Approach bias modification (ApBM) is a promising form of cognitive training for preventing/reducing alcohol use that can be delivered via smartphone. This study explored the acceptability and preliminary effectiveness of smartphone delivered and personalised ApBM amongst Australians
-
Psychological predictors of vaping uptake among non‐smokers: A longitudinal investigation of New Zealand adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-04 Tamlin S. Conner, Grace E. Teah, Chris G. Sibley, Robin M. Turner, Damian Scarf, Andre Mason
IntroductionDemographic and health factors are known to predict vaping. Less is known about psychological predictors of vaping uptake, particularly among non‐smoking adults using longitudinal designs. We aimed to model how psychological factors related to personality and mental health predicted the likelihood of vaping uptake over time in non‐smoking adults ages 18+ using longitudinal data.MethodsLongitudinal
-
Adulteration and substitution of drugs purchased in Australia from cryptomarkets: An analysis of Test4Pay Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-04 Monica J. Barratt, Matthew Ball, Gabriel T. W. Wong, Angus Quinton
IntroductionProhibited drugs in unregulated markets may be adulterated, resulting in increased risks for people who use drugs. This study investigated levels of drug adulteration and substitution of drugs purchased in Australia from cryptomarkets.MethodsData were collected from a darknet forum called Test4Pay from 1 September 2022 to 23 August 2023. Posts were included if they reported the results
-
A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-03-01 Jennifer L. Smith, Shaun Greene, David McCutcheon, Courtney Weber, Ellie Kotkis, Jessamine Soderstrom, Bianca Douglas, Simon Lenton, Jodie Grigg, Paul Dessauer, Nadine Ezard, Daniel M. Fatovich
Gamma-hydroxybutyrate (GHB) use is associated with high risk of accidental overdose. This study examined the pre-hospital circumstances, demographic characteristics and clinical outcomes of analytically confirmed GHB emergency department (ED) presentations in Western Australia (WA).
-
-
-
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Thileepan Naren, Jon Cook, Paul MacCartney, Dean Membrey
This case series records a cohort of patients treated with transdermal buprenorphine patches as part of a buprenorphine microdose induction protocol to transition from methadone to buprenorphine in a community setting. This has historically been a difficult process to manage in community settings and this case series explored a method to gradually manage this in an outpatient setting.
-
Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017–2022 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Nicole D. Fitzgerald, Joseph J. Palamar
Ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) is a drug commonly used by people who attend electronic dance music (EDM) events at nightclubs and dance festivals. Drug checking has gained popularity in recent years to test for adulterants, but epidemiology studies are needed to estimate potential shifts in prevalence of drug checking to further inform harm reduction efforts.
-
Youth drinking in decline: Recent developments and future priorities Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Michael Livingston, Nic Taylor, Jonas Raninen, Amy Pennay
The decline in young people's drinking across high income countries has been a topic of research for nearly a decade now, with studies clearly establishing declines in drinking across a range of measures and settings [1, 2]. Meanwhile efforts to pin down clear drivers of these trends or to better understand their longer-term implications have produced less consistent results [3]. As has been argued
-
Health utility among people who regularly use opioids in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-26 Anh Dam Tran, Jason Grebely, Mark Chambers, Louisa Degenhardt, Michael Farrell, Sahar Bajis, Briony Larance
IntroductionStudies of health utilities among people who use opioids have mostly been based on in‐treatment populations. We aim to report utility‐based quality of life by participants' socio‐demographic, drug and treatment characteristics, and to examine the determinants of health utility among people who use opioids regularly.MethodsCross‐sectional study of participants who used opioids regularly
-
Socio-economic inequities in emergency department visits for wholly alcohol-attributable acute and chronic harms in Canada, 2003–2017 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-22 Claire Benny, Erin Hobin, Alessandra T. Andreacchi, Naomi Schwartz, Brendan T. Smith
Individuals with low socio-economic position (SEP) experience disproportionate alcohol-attributable harm. Limited research has investigated whether these inequities are driven by alcohol-attributable conditions that are acute or chronic. The study aimed to estimate the sex-specific associations between SEP and incident wholly alcohol-attributable emergency department (ED) visits for acute and chronic
-
Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022 Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-12 Shane Darke, Johan Duflou, Amy Peacock, Agata Chrzanowska, Wing See Yuen, Michael Farrell, Julia Lappin
Acute alcohol toxicity is a significant component of alcohol-related mortality. The study aimed to: (i) determine the circumstances of death and characteristics of fatal alcohol toxicity cases, 2011–2022; (ii) determine their toxicological profile and major autopsy findings; and (iii) determine trends in population mortality rates.
-
Differences in stigma reduction related to injection drug use between people expressing conservative, moderate and progressive values following an online intervention Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-12 Theresa Caruana, Loren Brener, Sarah K. Calabrese, Elena Cama, Carla Treloar, Timothy Broady
Contact interventions have shown short-term effectiveness in reducing stigmatising attitudes and behaviours of the public towards marginalised population groups, including people who inject drugs. We theorised that the effectiveness of an intervention differs according to peoples' underlying social values and undertook a study to test this.
-
Policies for recovery from drug use: Differences between public stigma and perceived stigma and associated factors Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-07 Tingyu Luo, Shuping Xu, Kun Zhang
Public stigma towards people who use drugs is widespread and places obstacles in way of their recovery. Previous studies have used different approaches to measure public stigma, resulting in a notable gap in the understanding of the relationship between it and its associated factors. Some studies measure public stigma by assessing stigma perceived by those who use drugs, while others investigate attitudes
-
Approaches and reporting of alcohol and other drug testing for injured patients in hospital-based studies: A systematic review Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-05 Georgina Lau, Jia Y. Ang, Nayoung Kim, Belinda J. Gabbe, Biswadev Mitra, Paul M. Dietze, Sandra Reeder, Ben Beck
Hospital alcohol and/or other drug (AOD) testing is important for identifying AOD-related injuries; however, testing methods vary. This systematic review aimed to examine biological AOD testing methods from hospital-based studies of injured patients and quantify what proportion reported key information on those testing methods.
-
Alcoholic beverage types consumed by population subgroups in the United States: Implications for alcohol policy to address health disparities Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-02-05 Won Kim Cook, William C. Kerr, Yachen Zhu, Sophie Bright, Charlotte Buckley, Carolin Kilian, Aurelie M. Lasserre, Laura Llamosas-Falcón, Nina Mulia, Jürgen Rehm, Charlotte Probst
We aimed to identify alcoholic beverage types more likely to be consumed by demographic subgroups with greater alcohol-related health risk than others, mainly individuals with low socio-economic status, racial/ethnic minority status and high drinking levels.
-
Effects of the Sacramento Neighborhood Alcohol Prevention Project on rates of child abuse and neglect 7 years post-implementation (1999–2010) Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-30 Bridget Freisthler, Jennifer Price Wolf
Evaluations of alcohol environmental prevention efforts examine short-term effects of these interventions on alcohol-related problems. We examine whether the effects of the Sacramento Neighborhood Alcohol Prevention Project (SNAPP), an alcohol environmental intervention aimed to reduce alcohol-related problems in two neighbourhoods, on child abuse and neglect remained 7 years post-implementation.
-
Typologies of alcohol and other drug-related risk among lesbian, gay, bisexual, transgender (trans) and queer adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-30 Thomas Norman, Adam Bourne, Natalie Amos, Jennifer Power, Joel Anderson, Gene Lim, Marina Carman, G. J. Meléndez-Torres
Prevalence and patterns of alcohol and other drug (AOD) use among specific lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ+) subpopulations are well established. However, patterns of substance-related risk have been less thoroughly explored. This study aimed to determine typologies AOD risk among LGBTQ+ adults in Australia.
-
Acute REM sleep behaviour disorder associated with alcohol withdrawal: A case report and literature review Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-29 Radhika Chakraborty, Tathagata Biswas, Biswa Ranjan Mishra, Arpit Parmar
Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia characterised by the loss of REM sleep muscle atonia and the enactment of dreams. Acute RBD associated with alcohol withdrawal syndrome is known, but the studies are limited, particularly on its neurobiological underpinnings and management alongside the withdrawal state. This work attempts to address this using a case study and
-
Advancing the implementation of take-home naloxone by community pharmacists: Testing the role of COM-B Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-29 Joanna C. Moullin, Lexy Staniland, Hannah Uren, Suzanne Nielsen, Simon Lenton
Opioid-related overdose fatalities are rising despite the increased accessibility of take-home naloxone (THN). Targeted implementation strategies are needed to improve the distribution of naloxone. This study investigates the effectiveness of a short video targeting pharmacists that addresses implementation barriers.
-
How did COVID-19 restrictions impact alcohol consumption in Australia? A longitudinal study Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-28 Yvette Mojica-Perez, Michael Livingston, Amy Pennay, Sarah Callinan
The state of Victoria experienced more stringent public health measures than other Australian states during the COVID-19 pandemic. This study investigated how these public health measures impacted: (i) total alcohol consumption; (ii) location-specific consumption; and (iii) consumption among different pre-pandemic drinking groups, in Victoria compared to the rest of Australia during the first year
-
Experiences of stigma and subsequent reduced access to health care among women who inject drugs Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-25 Loren Brener, Elena Cama, Timothy Broady, Mary Ellen Harrod, Carol Holly, Theresa Caruana, Kim Beadman, Carla Treloar
Research into stigma and injecting drug use has typically involved predominantly male participants, with limited research about the unique experience of women who inject drugs.
-
Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-23 Sharon Lipperman-Kreda, Emile Sanders, Rachelle Annechino, Elaina Peterkin, Tamar M. J. Antin
To address gaps in existing research, the current study used a mixed-methods approach to describe, contextualise and understand harm perceptions of vaping nicotine relative to cigarette smoking and associations with nicotine and tobacco (NT) use among young adults who identify their genders and sexualities in ways that classify them as sexual and gender minorities (SGM).
-
Did the association between alcohol outlet density and crime change during COVID shelter-in-place orders? Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-23 Sharon E. O'Hara, Mallie J. Paschall, Joel W. Grube, William R. Ponicki
We investigated whether greater concentrations of on- and off-sale alcohol outlets were associated with crime and whether this association was moderated by COVID-19 shelter-in-place orders (SIP) that restricted on-premises consumption of alcohol.
-
Impacts of Northern Territory banned drinker register on police recorded youth assault Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-17 Ryan Baldwin, Peter G. Miller, Kerri Coomber, Debbie Scott, Yin Paradies
In September 2017 the Northern Territory Government of Australia introduced a banned drinker register (BDR) to mitigate the high levels of alcohol-related harm within the Northern Territory. The current study aimed to examine the impact of the Northern Territory BDR on youth (aged <18 years) using police recorded assault data.
-
Individuals' travel to alcohol outlets: The fallacy of the local bar Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-11 Christina A. Mehranbod, Ariana N. Gobaud, Brady R. Bushover, Christopher N. Morrison
Studies relating alcohol outlet density around homes to alcohol consumption produce mixed results. One possible explanation is that people travel to outlets away from their homes. This study aims to characterise individuals' trips to outlets, describe these trip locations relative to other activities and estimate associations between alcohol outlet density and trips to outlets.
-
Factor structure of the alcohol expectancies questionnaire among adolescents in rural Ghana Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-06 Benedict Weobong, Rebecca L. Monk, Maria Anyorikeya, Adam W. Qureshi, Derek Heim
Children's early experiences with alcohol inform the development of alcohol-related beliefs which are known to predict alcohol consumption during the critical stage of adolescence. Yet, there has been considerably less research into these alcohol-related cognitions in low- and middle-income countries (LMIC) and existing measures of these beliefs are highly reflective of Western contexts, which may
-
The economic costs of alcohol-related harms at the local level in New South Wales Drug Alcohol Rev. (IF 4.042) Pub Date : 2024-01-03 Paul Crosland, Mary Rose Angeles, Jonathon Noyes, Arlita Willman, Melissa Palermo, Paul Klarenaar, Eloise Howse, Jaithri Ananthapavan
Alcohol is a harmful, toxic and addictive substance that causes many diseases and injuries. Alcohol use also incurs a financial cost to the health care system and wider economy. This project aimed to undertake a cost impact analysis of alcohol-related harms at the local level in New South Wales (NSW). The alcohol-related harms costing model is an interactive tool designed for use by local health districts
-
Experiences of telehealth among people receiving alcohol and other drug treatment during the COVID-19 pandemic: Implications for future telehealth delivery Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-28 Jaimie Woolley, Michael Savic, Joshua B. B. Garfield, Rachel Petukhova, Victoria Manning, Dan I. Lubman, Anthony Barnett
The novel coronavirus (COVID-19) pandemic necessitated the rapid uptake of telehealth to deliver treatment for alcohol and other drug (AOD) concerns. However, little is known about how the move from in-person to telehealth delivery impacted clients' experience of care. This qualitative study aimed to explore experiences of telehealth among people receiving alcohol and other drug treatment during the
-
Parents who inject drugs: Demographics, care arrangements and correlates for child placement in out-of-home care Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-26 Jocelyn Chan, Bernadette Ward, Lisa Maher, Sione Crawford, Mark Stoové, Paul Dietze
Children in families affected by substance use disorders are at high risk of being placed in out-of-home care (OOHC). We aimed to describe the characteristics of parents who inject drugs and identify correlates associated with child placement in OOHC.
-
A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-25 Harrison Fursman, Eleanor Finch, Linda Xiao, Elodie Lefrançois, Anjali Gupta, Mark Bartlett, Julie Latimer, Scott Chadwick, Claude Roux, Marie Morelato
The administration of illicit drugs by injection is associated with considerable harm, including an increased risk of overdose. The chemical analysis of used syringes can enhance knowledge on injecting drug consumption beyond traditional data sources (self-report surveys). This additional information may be useful during significant global events like the COVID-19 pandemic. This study aimed to examine
-
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort) Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-22 Tangui Barré, Marc Bourlière, Lucia Parlati, Clémence Ramier, Fabienne Marcellin, Camelia Protopopescu, Vincent Di Beo, Carole Cagnot, Celine Dorival, Jérôme Nicol, Fabien Zoulim, Fabrice Carrat, Patrizia Carrieri
The risk of mortality in people with a history of injection drug use (PHID) is high, as is the prevalence of hepatitis C virus (HCV) infection. Although direct-acting antivirals (DAA) are effective in this population in terms of sustained virological response, it is not known whether PHID benefit as much as people with no history of injection drug use from DAA-related HCV cure in terms of reduced all-cause
-
Tobacco consumption in Mozambique in 2005 and 2015 Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-22 Filipa Fontes, António Suleman, Carla Silva-Matos, Celina Mate, Celeste Amado, Albertino Damasceno, Nuno Lunet
The burden related to smoking exposure is growing in many low-income settings. We aimed to quantify the use of smoked and smokeless tobacco in Mozambique in 2014/2015, and to compare the estimates with those obtained in 2005.
-
Cannabis vaporisation: Understanding products, devices and risks Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-20 Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April Christiansen, Michael Boivin
Vaporisation is a common method of cannabis administration. Inconsistent terminology and jargon regarding vaporisation has led to confusion. The increasing public interest and access to cannabis, combined with possible safety concerns associated with certain cannabis vaping products, warrants improved consumer and public and health care professional knowledge.
-
Future nicotine use preferences of current cigarette smokers: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-19 Lin Li, Ron Borland, Michael Le Grande, Coral Gartner
Consumer preferences should be important factors that are considered when developing health policies and interventions. This paper examines the prevalence of, and factors associated with, consumer preferences regarding smoking behaviour 1 to 2 years in the future.
-
Have the personality and socio-demographic profiles of Australian adolescent drinkers changed? Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-18 Nicholas Taylor, Sarah Callinan, Amy Pennay, Michael Livingston
Adolescent alcohol consumption has been declining across many countries, with rates of abstinence also increasing among younger cohorts. A range of socio-demographic variables and personality traits are associated with alcohol use; however, no study has examined whether the relationship between personality and drinking has changed over time as adolescent drinking has declined.
-
Barriers and facilitators to the implementation of the Flinders Chronic Condition Management Program in outpatient drug and alcohol settings in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-14 Candice Oster, Sarah Hunter, Timothy Schultz, Gillian Harvey, Michael Lawless, Malcolm Battersby
There has been a growing call for drug and/or alcohol dependence to be managed as a chronic condition. The Flinders Chronic Condition Management Program (Flinders Program) was implemented in a drug and alcohol service in Australia in 2019–2022 to explore the feasibility of chronic condition management in outpatient clinics. Implementation involved: adaptation of the Flinders Program; adaptation of
-
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-14 Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Canada has been experiencing a prolonged public health-crisis of high rates of overdose deaths caused by exceptionally potent/toxic, illicit opioid use. While many key features of this drug death epidemic are well-documented, several idiosyncratic aspects with relevance for public health-oriented interventions are not adequately recognised. These include: (i) the discrepant opioid patterns pan-Canada
-
Participation in Australian drug treatment programs for individuals engaging in high-risk substance use: Data from a nationally representative sample Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-12 Janni Leung, Tesfa Mekonen Yimer, Vivian Chiu, Wayne D. Hall, Jason P. Connor, Gary Chung Kai Chan
Substance use, including drugs, alcohol and smoking have a significant health, social and economic impact. We aim to assess the rate and factors associated with treatment access among individuals with high-risk substance use.
-
Police-recorded adult sexual assault in the Northern Territory, Australia: Alcohol involvement and alcohol policy effects Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-06 Sarah Clifford, Cassandra J. C. Wright, Peter G. Miller, Ryan Baldwin, Kalinda E. Griffiths, James A. Smith, Michael Livingston
Between 2017 and 2018 three major alcohol policy changes were introduced in the Northern Territory (NT): the Banned Drinker Register, an individual-level ban enforced via ID scanners at takeaway outlets; a Minimum Unit Price on alcohol; and Police Auxiliary Liquor Inspectors, who monitor takeaway outlets to prevent purchase by people who do not have a legal place to consume alcohol. We aimed to: (i)
-
Early closing of hotels: Impacts on alcohol consumption, drunkenness, liver disease and injury mortality Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-04 David R. Dunt, Heng Jiang, Robin Room
Early (six o'clock) closing of hotels was introduced in 1916 in Australia to curb heavy drinking. It lasted between 21 and 51 years in four Australian states. The aim of this study is to assess the impact of early closing on alcohol consumption, liver disease mortality rates, drunkenness and various forms of injury.
-
Characteristics of high- and low-risk drinkers who use online alcohol home delivery in Western Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-04 Kerri Coomber, Ryan Baldwin, Nicholas Taylor, Sarah Callinan, Claire Wilkinson, John W. Toumbourou, Tanya Chikritzhs, Peter G. Miller
Variation in alcohol availability is an important driver of levels of consumption and harm, with recent increases in online alcohol home delivery use expanding availability. There is limited research on the impacts of these changes and the characteristics of consumers who use alcohol home delivery.
-
Quantifying access to on-demand alcohol in New Zealand Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-03 Rose Crossin, Dru Norriss, Christina McKerchar, Gemma Martin, Tessa Pocock, Angela Curl
On-demand delivery (<2 h from ordering) of alcohol is relatively new to New Zealand. We aimed to quantify the number of services available and the number of outlets available to purchase from within on-demand services. We then tested whether access differed by neighbourhood demographics.
-
Here to stay? Policy changes in alcohol home delivery and “to-go” sales during and after COVID-19 in the United States Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-12-01 Julia M. Lemp, Carolin Kilian, Charlotte Probst
During the early phase of the COVID-19 pandemic, legislative changes that expanded alcohol home delivery and options for “to-go” alcohol sales were introduced across the United States to provide economic relief to establishments and retailers. Using data from the Alcohol Policy Information System, we examined whether these changes have persisted beyond the peak phase of the COVID-19 emergency and explored
-
Trends in alcohol-related harm among Swedish youth: Do in-patient care registry data match drinking trends? Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-29 Martin Stafström, Jonas Raninen
Youth drinking has been declining in Sweden since the year 2000. There is a paucity of studies examining trends in alcohol-related harm during this period. The overall aim of the present study is to examine how trends in alcohol-related harm match trends in drinking among Swedish youths during 2000–2021.
-
How is substance use portrayed in digital media and what impacts can it have? Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-28 Benjamin Riordan, Damian Scarf, Jennifer E. Merrill, Megan S. C. Lim, Emmanuel Kuntsche
In 2021, Facebook Inc. changed its name to Meta. At first glance, the updated name simply reflected that the company had grown to own not just the Facebook platform, but also Instagram, Threads, WhatsApp and a desire to branch out and include virtual reality [1]. The term “meta,” however, has a deeper meaning. Meta is short for metaverse, a word coined by Neal Stephenson in his dystopian novel Snow
-
Generating political priority for alcohol policy reform: A framework to guide advocacy and research Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-28 Ryan Gage, Jennie Connor, Nicki Jackson, Christina McKerchar, Louise Signal
While effective policies exist to reduce alcohol-related harm, political will to enact them is low in many jurisdictions. We aimed to identify key barriers and strategies for strengthening political priority for alcohol policy reform.
-
Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001–2019) Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-28 Sameer Imtiaz, Yeshambel T. Nigatu, Marcos Sanches, Farihah Ali, Angela Boak, Laura Douglas, Hayley A. Hamilton, Jürgen Rehm, Sergio Rueda, Robert M. Schwartz, Samantha Wells, Tara Elton-Marshall
Cannabis legalisation was enacted on 17 October 2018 in Canada. Accordingly, the effects of cannabis legalisation on patterns of cannabis consumption were examined among adolescents, including on cannabis initiation, any cannabis use, daily cannabis use and cannabis dependence.
-
Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-27 Robert Stirling, Suzie Hudson, Joanne Ross, Emily Deans, Joel Tibbetts, Carolyn Day, Rachel Deacon, Adrian Dunlop, Nicholas Lintzeris
Enhancing health system research capacity can support improved quality care. This study assessed the research capacity of public local health district (LHD) and non-government organisation (NGO) alcohol and other drug (AOD) services, at the organisational, team and individual level. Research barriers and motivators were also examined.
-
Trends in illicit drug use and their association with HIV transmission risks from behavioural surveillance of Australian gay and bisexual men Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-27 Jumpei Takeuchi, Curtis Chan, James MacGibbon, Timothy R. Broady, Toby Lea, Limin Mao, Benjamin R. Bavinton, Martin Holt
Investigating drug trends among Australian gay and bisexual men (GBM) is crucial for understanding levels of use and the potential for harm, including HIV transmission risk.
-
‘The convenience is a double-edged sword’: Qualitative interviews with people who use online alcohol delivery services Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-27 Stephanie Colbert, Louise Thornton, Claire Wilkinson, Xiaoqi Feng, Robyn Richmond
The past decade has seen a shift towards online purchasing and home delivery of alcohol, with this trend accelerated due to the COVID-19 pandemic. However, research in this area is limited. This study aims to explore how and why people use online alcohol delivery services.
-
Estonian alcohol control legislation in 1990–2020: A narrative review Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-27 Relika Stoppel, Rainer Reile, Andri Ahven, Kersti Pärna
The aim of this narrative review is to provide a detailed, chronological overview on the development of Estonian alcohol control legislation during 1990–2020.
-
Epidemiology of acute infections in people who inject drugs in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-23 Lucy O. Attwood, Daniel O'Keefe, Peter Higgs, Olga Vujovic, Joseph S. Doyle, Andrew J. Stewardson
People who inject drugs are at risk of acute infections, such as skin and soft tissue infections, infective endocarditis, bone and joint infections and bloodstream infections. There has been an increase in these infections in people who inject drugs internationally over the past 10 years. However, the local data regarding acute infections in Australia has not been well described.
-
Daily diary study of associations between alcohol, cannabis, co-use and sleep quality in individuals with intentions to use cannabis to cope with anxiety Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-20 Sharon R. Sznitman, Renée Martin-Willett, WenHao Ma, Hollis C. Karoly, L. Cinnamon Bidwell
Sleep problems and anxiety conditions are common comorbidities and may be influenced by cannabis and alcohol use. This study examined daily within-person variation in subjective sleep quality among individuals with anxiety symptoms after cannabis or alcohol were used alone, and after co-use.
-
Estimation of integrated price elasticities for alcohol and tobacco in the United Kingdom using the living costs and food survey 2006–2017 Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-12 Robert Pryce, Luke B. Wilson, Duncan Gillespie, Colin Angus, Damon Morris, Alan Brennan
Evidence shows that price is an important policy lever in reducing consumption of alcohol and tobacco. However, there is little evidence of the cross-price effect between alcohol and tobacco.
-
Information acquisition and dissemination among a sample of people who inject drugs in Australia Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-12 Rachel Sutherland, Amy Peacock, Sione Crawford, Carol Holly, Peta Gava, Jane Dicka, Geoff Manu, Jude Byrne
This paper examines the acquisition and dissemination of harm reduction information among people who inject drugs, as well as preferred sources of information.
-
The gendered violence of injecting-related stigma among relatively affluent, suburban women who inject drugs Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-12 George Christopher Dertadian, Theresa Caruana, Lisa Maher
In honouring the legacy of Jude Byrne's life-long advocacy for women and mothers who use drugs, this paper presents a case study of a group of women about whom we know little about and hear even less from: women who inject drugs in relatively affluent suburbs.
-
The impact of pseudoephedrine regulation at Australian pharmacies through Project Stop: A narrative review Drug Alcohol Rev. (IF 4.042) Pub Date : 2023-11-14 Samuel Brookfield, Coral Gartner
Project Stop, a real-time monitoring program for pseudoephedrine-containing medicines, was initiated in 2005 by the Pharmacy Guild of Australia in collaboration with police in the state of Queensland. The program implemented an online database to record pseudoephedrine purchases (and attempted purchases) to prevent large-scale diversion to methamphetamine production.